BIO 2019 Notebook: Merck; RMAT; Out-Licensing Deals

 
• By Joseph Haas and Sue Sutter
  
Bio 2019 Notebook for Pink
A total of 36 products within the purview of FDA's tissues/advanced therapies office have received RMAT and 32 got BTD. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Cell & Gene Therapies

More from Advanced Technologies